-Heterocyclic Carbene-Iridium Complexes As Photosensitizers for In Vitro Photodynamic Therapy to Trigger Non-Apoptotic Cell Death in Cancer Cells

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2023 Jan 21

PMID 36677751

Authors

Xing Wang

Chen Zhang

Ryma Madji

Camille Voros

Serge Mazeres

Christian Bijani

Celine Deraeve

Olivier Cuvillier

Heinz Gornitzka

Marie-Lise Maddelein

Catherine Hemmert

Affiliations

Soon will be listed here.

Abstract

A series of seven novel iridium complexes were synthetized and characterized as potential photosensitizers for photodynamic therapy (PDT) applications. Among them, four complexes were evaluated in vitro for their anti-proliferative activity with and without irradiation on a panel of five cancer cell lines, namely PC-3 (prostate cancer), T24 (bladder cancer), MCF7 (breast cancer), A549 (lung cancer) and HeLa (cervix cancer), and two non-cancerous cell models (NIH-3T3 fibroblasts and MC3T3 osteoblasts). After irradiation at 458 nm, all tested complexes showed a strong selectivity against cancer cells, with a selectivity index (SI) ranging from 8 to 34 compared with non-cancerous cells. The cytotoxic effect of all these complexes was found to be independent of the anti-apoptotic protein Bcl-xL. The compound exhibiting the best selectivity, complex , was selected for further investigations. Complex was mainly localized in the mitochondria. We found that the loss of cell viability and the decrease in ATP and GSH content induced by complex were independent of both Bcl-xL and caspase activation, leading to a non-apoptotic cell death. By counteracting the intrinsic or acquired resistance to apoptosis associated with cancer, complex could be an interesting therapeutic alternative to be studied in preclinical models.

References

Qin W, Pan Z, Cai D, Li Y, He L . Cyclometalated iridium(iii) complexes for mitochondria-targeted combined chemo-photodynamic therapy. Dalton Trans. 2020; 49(11):3562-3569. DOI: 10.1039/d0dt00180e. View

Yusoh N, Ahmad H, Gill M . Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy. ChemMedChem. 2020; 15(22):2121-2135. PMC: 7754470. DOI: 10.1002/cmdc.202000391. View

He L, Tan C, Ye R, Zhao Y, Liu Y, Zhao Q . Theranostic iridium(III) complexes as one- and two-photon phosphorescent trackers to monitor autophagic lysosomes. Angew Chem Int Ed Engl. 2014; 53(45):12137-41. DOI: 10.1002/anie.201407468. View

Yang Y, Guo L, Tian Z, Gong Y, Zheng H, Zhang S . Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents. Inorg Chem. 2018; 57(17):11087-11098. DOI: 10.1021/acs.inorgchem.8b01656. View

Gu Y, Wen H, Bai L, Zhou Y, Zhang H, Tian L . Exploring anticancer efficiency of mitochondria-targeted cyclometalated iridium(III) complexes. J Inorg Biochem. 2020; 212:111215. DOI: 10.1016/j.jinorgbio.2020.111215. View

Lam T, Tong K, Yang C, Kwong W, Guan X, Li M . Luminescent ruffled iridium(iii) porphyrin complexes containing N-heterocyclic carbene ligands: structures, spectroscopies and potent antitumor activities under dark and light irradiation conditions. Chem Sci. 2019; 10(1):293-309. PMC: 6335621. DOI: 10.1039/c8sc02920b. View

Imberti C, Zhang P, Huang H, Sadler P . New Designs for Phototherapeutic Transition Metal Complexes. Angew Chem Int Ed Engl. 2019; 59(1):61-73. PMC: 6973108. DOI: 10.1002/anie.201905171. View

Sperandio S, de Belle I, Bredesen D . An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci U S A. 2000; 97(26):14376-81. PMC: 18926. DOI: 10.1073/pnas.97.26.14376. View

Yang C, Beltran J, Lemaur V, Cornil J, Hartmann D, Sarfert W . Iridium metal complexes containing N-heterocyclic carbene ligands for blue-light-emitting electrochemical cells. Inorg Chem. 2010; 49(21):9891-901. DOI: 10.1021/ic1009253. View

10.

Vit J, Guillouf C, Rosselli F . Futile caspase-8 activation during the apoptotic cell death induced by DNA damaging agents in human B-lymphoblasts. Exp Cell Res. 2001; 269(1):2-12. DOI: 10.1006/excr.2001.5284. View

11.

Zhang P, Huang H, Banerjee S, Clarkson G, Ge C, Imberti C . Nucleus-Targeted Organoiridium-Albumin Conjugate for Photodynamic Cancer Therapy. Angew Chem Int Ed Engl. 2018; 58(8):2350-2354. PMC: 6468315. DOI: 10.1002/anie.201813002. View

12.

Liu J, Lai H, Xiong Z, Chen B, Chen T . Functionalization and cancer-targeting design of ruthenium complexes for precise cancer therapy. Chem Commun (Camb). 2019; 55(67):9904-9914. DOI: 10.1039/c9cc04098f. View

13.

Ma W, Ge X, Xu Z, Zhang S, He X, Li J . Theranostic Lysosomal Targeting Anticancer and Antimetastatic Agents: Half-Sandwich Iridium(III) Rhodamine Complexes. ACS Omega. 2019; 4(12):15240-15248. PMC: 6751730. DOI: 10.1021/acsomega.9b01863. View

14.

Kaufmann T, Schlipf S, Sanz J, Neubert K, Stein R, Borner C . Characterization of the signal that directs Bcl-x(L), but not Bcl-2, to the mitochondrial outer membrane. J Cell Biol. 2003; 160(1):53-64. PMC: 2172731. DOI: 10.1083/jcb.200210084. View

15.

Yokoi K, Balachandran C, Umezawa M, Tsuchiya K, Mitric A, Aoki S . Amphiphilic Cationic Triscyclometalated Iridium(III) Complex-Peptide Hybrids Induce Paraptosis-like Cell Death of Cancer Cells via an Intracellular Ca-Dependent Pathway. ACS Omega. 2020; 5(12):6983-7001. PMC: 7114882. DOI: 10.1021/acsomega.0c00337. View

16.

Li X, Wu J, Wang L, He C, Chen L, Jiao Y . Mitochondrial-DNA-Targeted Ir -Containing Metallohelices with Tunable Photodynamic Therapy Efficacy in Cancer Cells. Angew Chem Int Ed Engl. 2020; 59(16):6420-6427. DOI: 10.1002/anie.201915281. View

17.

He L, Li Y, Tan C, Ye R, Chen M, Cao J . Cyclometalated iridium(iii) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agents. Chem Sci. 2018; 6(10):5409-5418. PMC: 5947539. DOI: 10.1039/c5sc01955a. View

18.

Nam J, Kang M, Kang J, Park S, Lee S, Kim H . Endoplasmic Reticulum-Localized Iridium(III) Complexes as Efficient Photodynamic Therapy Agents via Protein Modifications. J Am Chem Soc. 2016; 138(34):10968-77. DOI: 10.1021/jacs.6b05302. View

19.

Bonhoure E, Lauret A, Barnes D, Martin C, Malavaud B, Kohama T . Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cells. Leukemia. 2008; 22(5):971-9. DOI: 10.1038/leu.2008.95. View

20.

He L, Zhang M, Pan Z, Wang K, Zhao Z, Li Y . A mitochondria-targeted iridium(iii)-based photoacid generator induces dual-mode photodynamic damage within cancer cells. Chem Commun (Camb). 2019; 55(70):10472-10475. DOI: 10.1039/c9cc04871e. View